Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Feb 16:10:2.
doi: 10.1186/1477-7517-10-2.

Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study

Joan L Bottorff  1 , Laura J L Bissell, Lynda G Balneaves, John L Oliffe, N Rielle Capler, Jane Buxton
Affiliations

Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study

Joan L Bottorff et al. Harm Reduct J. .

Abstract

Background: Despite its increasing prevalence and acceptance among the general public, cannabis use continues to be viewed as an aberrant activity in many contexts. However, little is known about how stigma associated with cannabis use affects individuals who use cannabis for therapeutic purposes (CTP) and what strategies these individuals employ to manage associated stigma. The aim of this Canadian study was to describe users' perceptions of and responses to the stigma attached to using CTP.

Methods: Twenty-three individuals who were using CTP for a range of health problems took part in semi-structured interviews. Transcribed data were analyzed using an inductive approach and comparative strategies to explore participants' perceptions of CTP and identify themes.

Results: Participant experiences of stigma were related to negative views of cannabis as a recreational drug, the current criminal sanctions associated with cannabis use, and using cannabis in the context of stigmatizing vulnerability (related to existing illness and disability). Strategies for managing the resulting stigma of using CTP included: keeping CTP 'undercover'; educating those who did not approve of or understand CTP use; and using cannabis responsibly.

Conclusions: Understanding how individuals perceive and respond to stigma can inform the development of strategies aimed at reducing stigma associated with the use of CTP and thereby address barriers faced by those using this medicine.

PubMed Disclaimer

References

    1. Tramer MR, Carroll D, Campbell F, Reynolds DJM, Moore A, McQuay H. Cannabinoids for control of chemotherapy induced nausea and vomiting: Quantitative systematic review. BMJ. 2001;323(16):1–8. - PMC - PubMed
    1. Ware M, Rueda S, Singer J, Kilby D. Cannabis use by persons living with HIV/AIDS: Patterns and prevalence of use. J Cannabis Therapeutics. 2003;3(2):3–15. doi: 10.1300/J175v03n02_02. - DOI
    1. Hathaway AD. Cannabis users' informal rules for managing stigma and risk. Deviant Behav. 2004;25(6):559–577. doi: 10.1080/01639620490484095. - DOI
    1. Tjepkema M. Use of cannabis and other illicit drugs. Health Rep. 2004;15(4):41–47. - PubMed
    1. Stockwell T, Sturge J, Jones W, Fischer B, Carter C. Cannabis use in British Columbia: Patterns of use, perceptions, and public opinion as assessed in the 2004 Canadian Addiction Survey - Bulletin 2. Centre for Addictions Research of British Columbia (CARBC), Vancouver, Canada; 2004. http://carbc.ca/Portals/0/PropertyAgent/558/Files/19/CARBCBulletin2.pdf.

Publication types

MeSH terms